November 11, 2024 · Form 4 insider transaction
Draghia-Akli Ruxandra bought 42,770 shares of Novavax, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.; One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.